secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2025-04-16T23:59:59+00:00
Accession:  0000950170-25-054707
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma transfers to Nasdaq Capital Market; must regain $1 bid price by Oct 13, 2025
--------------------------------------------------------------------------------

- Approved transfer from Nasdaq Global Select Market to Capital Market effective April 17, 2025.
- Failed to meet $1 minimum bid price; granted 180-day grace period until October 13, 2025.
- Must have bid price ≥ $1 for ten consecutive business days during grace period to regain compliance.
- Seeking stockholder approval for reverse stock split at its 2025 annual meeting.
- Stock continues trading under symbol 'ATHA' on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017025054707/0000950170-25-054707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017025054707/atha-20250415.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-054707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer